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General introduction 
 
Unlike mammals, some animals, like the adult teleost and urodele amphibians, can 
completely regenerate their appendages after amputation [1]. Although mice have a 
good capacity for organ regeneration, the ability to regenerate is limited [2]. In contrast, 
the teleost and urodele amphibians have this regenerative capacity throughout their 
lifespan. What is the difference between the mammal and some other animals that have 
a great capacity for organ regeneration? Understanding of this fascinating phenomenon 
more deeply may be beneficial in the medical field because the mechanism may be 
applicable to disease management and healing in the future. 
As a potential model system for studying regeneration, the zebrafish has a lot of great 
advantages [3]. Firstly, they can regenerate organs relatively quickly throughout their 
lifespan, from the larvae stage to adulthood. Secondly, the sequence of their genome is 
known, so we can use the data set, forward genetic approaches, and some transgenics 
method. Finally, they can regenerate different kinds of organs such as the fin, brain, 
spinal cord, retina, and heart. Although each regeneration is induced each different 
system, but there are many common systems in same time. 
The zebrafish has become the predominant model, because of these advantages. In 
most cases of fin regeneration research, we use the caudal fin because we can easily 
amputate it and observe the process of regeneration [4]. Zebrafish fins can be observed 
simply as being a construction of bone rays, which provide the fin shape and structure. 
Bone rays are composed of two sets of hemi-rays that are segmented into each bone. 
The fin ray bones are thought to be regenerated via direct ossification rather than cell 
differentiation from some premature cells, while other cells are structured in some 
tissues by fibroblasts, nerves, blood vessels, pigment, and mesenchymal tissues. 
There are 3 steps in caudal fin regeneration [5][6][7]: wound healing, blastema 
formation, and regenerative outgrowth. Fin regeneration usually takes only 2 weeks to 
complete. 
 
1. Wound healing: 12 hours post amputation (hpa) 
Following fin amputation, epidermal cells cover the amputation plane within an hour, 
while some cells migrate to the plane. At the same time, the cells migrate to below the 
amputation plane and start forming the premature cells, called the blastema. 
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2. Blastema formation: 12-36 hpa 
From 12 hpa to 36 hpa, changed premature cells, the blastema, begin to have a 
capacity for cell proliferation. The blastema is a highly proliferative mass of 
undifferentiated mesenchymal cells from which several cell types will differentiate in 
order to form the missing structures. This is derived from existing cells before 
amputation.  
 
3. Regenerative outgrowth: 36 hpa~ 
Regenerative outgrowth is induced by cell proliferation and dedifferentiation from the 
blastema. Gradually, the fin grows back its original shape, completing the regeneration 
around 14 days. Some of the blastema cells aligning the epithelial tissue start to 
differentiate into the scleroblasts, a process which depends on each signal arising from 
the apical epithelial cap (AEC). Within the following 3 to 14 days, the interactions 
between the AEC and the blastema assure the outgrowth of the regenerating fin and 
during this process, all cell types are redifferentiated and a new caudal fin is established. 
The cell mass has been proposed to play a critical role in the regulation of gene 
expression pattern and outgrowth throughout the fin regeneration due to the gene 
expressions of the many growth factors, which are implicated in important signaling 
pathways to induce the blastema cells, such as Wnt/b-Catenin Signaling, Fibroblast 
growth factors, Insulin-like growth factors, and Sonic hedgehog. 
 
Recently, many researchers have tried to reveal the mechanism of regeneration, and 
they have reported new and important factors [8]. These include a lot of growth factors, 
immune system related factors, epigenetic modification related factors, and other factors 
involved in intercellular signaling pathways. However, a lot of details about the 
regeneration are still unknown and nobody can induce organ regeneration directly in the 
human body in the medical field.  
One of the unsolved points in regeneration research is how the amputated fin 
regenerates until the original shape is completed. This phenomenon is thought to be 
induced by some critical factors. Many researchers, including me, believe this 
mechanism can be explained by the general concept of positional memory [9]. 
In the regeneration fin, the original appendages' size, shape, and some pattern is 
restored. The regeneration requires that spared cells sustain or recall the information 
encoding pattern. But almost all factors have not been implicated as a key factor of the 
position-dependent regeneration during appendage regeneration. Recent work has 
produced cellular and molecular models for blastema formation and regenerative 
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outgrowth during fin regeneration, but the mechanism of storing the original shape’s 
information is still largely unknown. One paper about the mechanism has been reported 
in zebrafish fin regeneration [10]. During fin regeneration, the induction of cell 
proliferation mediated by Fgf signaling is different between the proximal and distal 
positions of the amputation plane. This induction starts at around 48 hpa and the late 
stage of regeneration follows this induction. Complete regeneration of the fin depends 
on the amputation position. However, nobody knows when this induction starts and 
what factor creates the difference.  
In our laboratory, a previous has reported that the mechanistic target of rapamycin 
(mTORC1) signaling is the one of the earliest inducted signaling pathways after fin 
amputation [12] and I have found that the pathway is related to the position-dependent 
induction in the zebrafish fin regeneration. Additionally, I have discovered the signaling 
pathway is regulated by v-ATPase/lysosomal acidification during fin regeneration and 
the amino acid transporter is also required for this regeneration. In this chapter, I show 
the distribution of lysosome acidification mediated by amino acid transporter during fin 
regeneration. Finally, in chapter 3, I discuss how the new mechanism is involved in 
position-dependent zebrafish fin regeneration. 
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Figure.  The process of fin regeneration 
Following amputation, epidermal cells migrate to cover the injured plane and form the wound 
epidermis. The inter-ray cells de-differentiate and migrate to the under wound epidermis until 24 
hpa. The de-differentiated cells begin to proliferate and form blastema. Formed blastema 
proliferate and re-differentiate, and regenerative outgrowth is induced. Finally, regeneration is 
completed for two weeks. 
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Chapter 2. Leucine/glutamine and v-ATPase/lysosomal 
acidification via mTORC1 activation are required for 
position-dependent regeneration. 
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Abstract 
  
In animal regeneration, control of position-dependent cell proliferation is crucial for the 
complete restoration of patterned appendages in terms of both, shape and size.  However, 
detailed mechanisms of this process are largely unknown.  In this study, we identified 
leucine/glutamine and v-ATPase/lysosomal acidification, via mechanistic target of 
rapamycin complex 1 (mTORC1) activation, as effectors of amputation plane-dependent 
zebrafish caudal fin regeneration.  mTORC1 activation, which functions in cell 
proliferation, was regulated by lysosomal acidification possibly via v-ATPase activity at 
3 h post amputation (hpa).  Inhibition of lysosomal acidification resulted in reduced 
growth factor-related gene expression and suppression of blastema formation at 24 and 
48 hpa, respectively.  Along the proximal-distal axis, position-dependent lysosomal 
acidification and mTORC1 activation were observed from 3 hpa.  We also report that 
Slc7a5 (L-type amino acid transporter), whose gene expression is position-dependent, is 
necessary for mTORC1 activation upstream of lysosomal acidification during fin 
regeneration.  Furthermore, treatment with leucine and glutamine, for both proximal and 
distal fin stumps, led to an up-regulation in cell proliferation via mTORC1 activation, 
indicating that leucine/glutamine signaling possesses the ability to change the position-
dependent regeneration.  Our findings reveal that leucine/glutamine and v-
ATPase/lysosomal acidification via mTORC1 activation are required for position-
dependent zebrafish fin regeneration. 
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Introduction 
 
Complete regeneration (in terms of both shape and size) of the patterned appendages is 
observed in some vertebrates such as fish and salamanders [1,2].  This restorative ability 
is achieved via cellular properties that control cell proliferation and patterning depending 
on regional-specific information, also known as positional memory [3-6].  To date, three 
factors (transmembrane receptor Prod1 [7,8], retinoic acid (RA) [5], and Hand2 [9]) have 
been proposed as effectors of the positional memory in salamander limbs, amphibian 
limbs, and zebrafish pectoral fins, respectively.  The expression of Prod1 and hand2 
exhibits a gradient along the proximal-distal (P-D) axis in salamander limbs 8 and 
zebrafish pectoral fins 9, respectively, while no gradient of the RA signaling components 
has been reported in salamander limbs or zebrafish fins prior to injury.  Although a 
recent report identified many genes, proteins, and metabolites via omics analyses in 
addition to Prod1, RA, and Hand2 along the P-D axis of the zebrafish caudal fin 10, the 
detailed molecular regulatory mechanisms of position-dependent regeneration are still 
largely unknown. 
Signaling molecules, such as transforming growth factor- (TGF-), Wnt, fibroblast 
growth factor (FGF), Notch, Hedgehog, insulin-like growth factor (IGF), RA, and 
mechanistic target of rapamycin (mTOR) have been determined to be necessary for 
appendage regeneration [11,12].  Among them, the mTOR is well known to sense 
environmental cues (growth factors, nutrients, and the cellular energy change) and control 
the cell growth and metabolism [13].  mTOR belongs to a serine/threonine protein 
kinase family and exists as two distinct complexes-mTOR complex1 (mTORC1) and 2 
(mTORC2) [13].  In the mTORC1 signaling pathway, growth factors, intracellular and 
environmental stresses (e.g. energy, oxygen, and DNA damage), and amino acids are 
known to be upstream regulators [14,15].  mTORC1 regulates cell growth via protein, 
lipid, and nucleotide synthesis, and it is also known to inhibit autophagy [14,15].  The 
amino acids, especially leucine, glutamine, and arginine, activate mTORC1 signaling via 
a lysosomal amino acid transporter (SLC38A9) and a RAS-related GTP-binding protein 
(Rag)/Regulator/vacuolar-type proton transporter H+-ATPase (v-ATPase) complex 
[14,15].  A previous report proved that the expression of v-ATPase demonstrated 
position-dependency and that the v-ATPase activity was necessary for the expression of 
aldehyde dehydrogenase 1 family, member A2 (aldh1a2) (a type of RA synthetase) during 
zebrafish caudal fin regeneration [16].  However, the function of the amino acids and 
SLC38A9/Rag/Regulator/v-ATPase complex in the position-dependent appendage 
regeneration process has not yet been reported. 
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Zebrafish caudal fins are complex appendages that are composed of epidermal cells, 
segmented bony rays, blood vessels, fibroblast-like mesenchymal cells, and nerve axons.  
Using zebrafish caudal fin regeneration systems, we have previously showed that 
mTORC1 signaling regulated cell proliferation, cell survival, and differentiation in 
zebrafish fin regeneration downstream of the IGF and Wnt pathways [17].  However, 
the regulation of mTORC1 activity via upstream regulators other than growth factors 
during fin regeneration has not yet been analyzed.  In this study, we explored the 
upstream regulators of mTORC1 and identified the axis of leucine/glutamine signaling-
v-ATPase/lysosomal acidification via mTORC1 activation as an effector of position-
dependent zebrafish caudal fin regeneration. 
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Results 
 
mTORC1 activation is not controlled by IGF and Wnt signaling at 3 h post 
amputation 
We have previously reported that mTORC1 activation was regulated by both IGF and 
Wnt signaling pathways at 24 and 48 h post amputation (hpa) during zebrafish fin 
regeneration by using pharmacological inhibitors, NVP-ADW742 (an IGF-1R inhibitor) 
and IWP-2 (a Wnt/-catenin inhibitor) [17].  However, amino acids and environmental 
stresses have been known to function as the upstream regulators of mTORC1 in addition 
to growth factors [14,15].  To explore the involvement of the upstream regulators other 
than growth factors in mTORC1 regulation, we carefully observed the expression of 
phosphorylated S6 kinase (p-S6K; activated form of S6K), a downstream target of 
mTORC1, during fin regeneration while IGF or Wnt signaling was inhibited.  The p-
S6K fluorescence intensities per area that consist of the whole regenerates and 500 m 
below the amputation plane were significantly reduced via rapamaycin (rapa) treatment 
(Fig. 1C-D’, G, H-I’, L, M-N’, and Q).  On the other hand, the p-S6K fluorescence 
intensities in IGF or Wnt signaling inhibited-fin stumps remained unchanged at 3 hpa 
(Fig. 1C, C’, and E-G), but were significantly reduced at 6 and 12 hpa when compared to 
those in the DMSO-treated fin stumps (Fig. 1H, H’, J-L, M, M’, and O-Q).  The results 
of p-S6K fluorescence intensities at 3 and 12 hpa observed by immunohistochemical 
staining were further supported by western blotting analysis (Fig. S1), indicating that 
mTORC1 activation is not under the control of IGF and Wnt signaling at 3 hpa during fin 
regeneration. 
 
Lysosomal acidification, possibly through v-ATPase, is required for mTORC1 
activation 
Previous studies using cell culture systems reported that the mTORC1 activation was 
closely linked to the SLC38A9/Rag/Regulator/v-ATPase complex on the lysosomal 
surface [13-15].  Interestingly, one of components in the lysosomal protein complex, v-
ATPase, is required for zebrafish fin regeneration [16].  Therefore, we first examined 
the activity of the proton transporter, v-ATPase, during fin regeneration with the help of 
the LysoTracker, which is a fluorescent dye for labelling acidic lysosomes.  High 
fluorescent signals of the LysoTracker were observed at 3 hpa at the amputation plane, 
which gradually decreased until 12 hpa (Fig. S2), showing the acidification of lysosomes 
during fin regeneration.  To examine the relationship between the activation of v-ATPase 
and mTORC1, we further examined the functional inhibition of v-ATPase by using two 
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different pharmacological inhibitors, Concanamycin A (ConcA) [18] and Bafilomycin A1 
(BafA1) [19].  We found that the p-S6K fluorescence intensity and p-S6K protein level 
were significantly reduced in each inhibitor-treated fin stump at 3 hpa by 
immunohistochemistry and western blotting, respectively (Fig. 2B-F).  Lysosomal 
acidification at the amputation plane was suppressed by ConcA or BafA1 treatment at 3 
hpa (Fig. 2G-J), suggesting that one of the mTORC1 regulators is a v-ATPase that 
regulates lysosomal acidification at this regeneration stage. 
To evaluate the lysosomal acidification on mTORC1 activation, we next examined 
the inhibition of lysosomal acidification via treatment of ammonium chloride (NH4Cl) or 
chloroquine (CQ), both of which are the weak bases and function to increase the 
lysosomal pH [20].  The reagent treatment lead to a significant reduction of the p-S6K 
fluorescence intensity and p-S6K protein level at 3 hpa by immunohistochemistry and 
western blotting, respectively (Fig. 3B-F).  We confirmed that lysosomal acidification 
was blocked in NH4Cl- or CQ-treated fin stumps at 3 hpa using LysoTracker (Fig. S3) 
and apoptosis was not increased by the reagent treatment at 3 and 24 hpa (Fig, S4).  The 
expression of growth factor-related genes (wnt10a, igf2b, aldh1a2, and fgf20a) [11,12] 
was significantly downregulated at 24 hpa in NH4Cl- or CQ-treated fin stumps (Fig. 3G).  
To further investigate the relationship between p-S6K and lysosomal acidification, we 
double stained fin stumps using the LysoTracker and p-S6K antibody.  Approximately 
55 % of the p-S6K-positive cells were LysoTracker-positive in the fin stumps at 3 hpa 
(Fig. 3H-K), suggesting an association between mTORC1 activation and lysosomal 
acidification.  Collectively, these results showed that lysosomal acidification is required 
to activate mTORC1 possibly via v-ATPase activity. 
 
Lysosomal acidification and mTORC1 activation are dependent on the amputation 
plane along the P-D axis 
A previous report showed that the expression of atp6v1e1b, a v-ATPase family gene, 
and the H+ efflux in the proximal regenerates were higher than those in the distal 
regenerates at 12 hpa [16].  These results prompted us to analyze whether the 
acidification of lysosome was dependent on the position of the amputation plane along 
the P-D axis.  LysoTracker fluorescence was detected at both proximal and distal 
amputation planes from 1 hpa (Fig. 4B-E’’).  The fluorescence intensities at the proximal 
regions were significantly higher than those at the distal regions, and this difference in 
fluorescence intensities remained until 6 hpa (Fig. 4F).  Cryosections under the confocal 
microscope showed that the fluorescent LysoTracker-positive cells were observed in the 
epidermis and fin rays of proximal and distal fin stumps at 3 hpa (Fig. 4G and H).  
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Moreover, the ratio of the fluorescent LysoTracker-positive cell number/total cell number 
(RLT) within the area that consist of the whole regenerates and 500 m below the 
amputation plane in proximal stumps was significantly higher than that in distal stumps 
at 3 hpa (Fig. 4I).  Because lysosomal acidification is required for mTORC1 activation, 
the position-dependence of p-S6K- and proliferating cell nuclear antigen (PCNA, a maker 
for proliferative cells [21])-positive cells was also examined during fin regeneration.  
We found that p-S6K fluorescence intensity and p-S6K protein level in the proximal 
regions were significantly higher than those in the distal regions during fin regeneration 
at 3 and 12 hpa by immunohistochemistry and western blotting, respectively (Fig. 5A-F).  
Consistent with previous results that reported the regulation of cell proliferation via 
mTORC1 [17], the ratios of PCNA-positive cell number/total cell number (RPTs) within 
the area that consist of the whole regenerates also showed dependence on the amputation 
plane at 36 and 48 hpa (Fig. 5G-K).  Our results suggest that position-dependent 
lysosomal acidification may cause the differences in mTORC1 activation between the 
proximal and distal amputation planes. 
 
L-type amino acid transporter 1 is required for mTORC1 activation 
Previous studies implicated branched-chain amino acids, especially leucine, and their L-
type amino acid transporters (LATs) as effective activators of mTORC1 [22-25].  
Because there are five LATs (LAT1; Slc7a5, LAT2; Slc7a8a and Slc7a8b, LAT3; Slc43a1a 
and Slc43a1b) in zebrafish as per the zebrafish database, we first examined the expression 
of these LATs at 0, 1, 3, 6, and 12 hpa.  Among them, slc7a5 showed the highest increase 
in expression levels at 3 hpa, and its expression in the proximal region was significantly 
higher than that in the distal region (Fig. 6A and Fig. S5).  Therefore, we further 
performed vivo-morpholino oligo nucleotide (MO)-mediated slc7a5 knockdown 
experiments during fin regeneration.  We first confirmed that a previously reported 
slc7a5-MO [26] blocked the exon1 splicing of slc7a5 pre-mRNA detected via 
quantitative real-time PCR (qPCR) (Fig. S6).  Formation of blastema, a heterogeneous 
population of progenitor cells, was suppressed in slc7a5-MO-injected fin regenerates 
when compared to in standard MO (st-MO)-injected fin regenerates at 48 hpa (Fig. 6C-
F).  Consistent with the suppressed blastema formation, p-S6K fluorescence intensity, 
p-S6K protein level, and expression of growth factor-related genes were significantly 
reduced in slc7a5-MO-injected fins (Fig. 6G-K).  We further found via LysoTracker 
analysis that lysosomal acidification was significantly reduced in slc7a5-MO-injected fin 
stumps when compared to in st-MO-injected fin stumps (Fig. 6L-N).  In addition to 
knockdown experiments, we have used a Slc7a5-specific inhibitor, JPH203 [27], to block 
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the cellular entry of amino acids.  Similar to vivo-MO mediated knockdown 
experiments, blastema formation at 48 hpa, the p-S6K fluorescence intensity, p-S6K 
protein level, and lysosomal acidification by LysoTracker were significantly reduced at 3 
hpa in JPH203-treated fin stumps when compared to those in DMSO-treated fins (Fig. 
S7).  These our findings suggest that amino acid signaling through the Slc7a5 transporter 
is involved in mTORC1 activation possibly via lysosomal acidification during fin 
regeneration. 
 
Treatment with leucine and glutamine increases mTORC1 signaling and cell 
proliferation in both proximal and distal fin stumps 
A recent study showed that mTORC1 signaling stimulated by leucine and glutamine 
rescues defects associated with Roberts Syndrome in zebrafish [28].  Based on this 
finding, we wondered if the amino acids, leucine and glutamine, were involved in 
mTORC1 activation during fin regeneration.  To explore this possibility, we carried out 
leucine and/or glutamine treatment in fin-amputated fish.  Fin stumps after leucine or 
glutamine treatment showed no increased mTORC1 activation (Fig. S8), whereas co-
treatment with leucine and glutamine (LG) significantly increased the p-S6K fluorescence 
intensity at 3, 6, 12 hpa and p-S6K protein level at 3 hpa in both proximal and distal fin 
stumps (Fig. 7B-G).  In addition, although LysoTracker fluorescence intensities were 
not increased by leucine or glutamine treatment (Fig. S9B-K), they showed an LG 
concentration-dependent increase in LG-treated fin stumps compared to control fin 
stumps at 3 hpa (Fig. S9L-P).  Consistent with increase of the p-S6K fluorescence 
intensities, RPTs in both proximal and distal regenerates were increased in LG-treated fin 
regenerates at 36 hpa (Fig. 7H-L).  We further found that LG treatment significantly 
increased the expression of growth factor-related genes, except wnt10a, at 24 hpa (Fig. 
7M).  These results showed that LG signaling had the ability to change position-
dependent cell proliferation via mTORC1 activation during fin regeneration.  Because 
it is known that amino acid signaling is one of upstream regulators of mTORC1 via the 
SLC38A9/Rag/Regulator/v-ATPase complex [13-15], we further tested the hierarchical 
relationship between LG signaling and v-ATPase/lysosomal acidification.  The p-S6K 
fluorescence intensity and p-S6K protein level were significantly increased by LG 
treatments at 3 hpa; however, this increased level of mTORC1 signaling was suppressed 
by the co-treatment with ConcA or NH4Cl (Fig. 7N-T).  Furthermore, up-regulation of 
LysoTracker fluorescence intensity by LG treatment was annulled by slc7a5-MO 
injection (Fig. S10).  Results of the LG signal activation experiments, combined with 
the slc7a5 knockdown data, suggest that LG and their transporter, Slc7a5, are upstream 
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regulators of mTORC1 activity via v-ATPase/lysosomal acidification. 
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DISCUSSION 
 
One of the most important processes in regeneration is the complete restoration of lost 
tissues or organs by cellular factors that regulate position-dependent cell proliferation and 
patterning (positional memory).  Because the mTORC1 signaling pathway plays a 
central role in cell proliferation via the production of proteins, lipids, and nucleotides, and 
suppression of catabolic pathways such as autophagy, it is a potent candidate effector of 
position-dependent regeneration.  In this study, we arrived at four conclusions.  First, 
lysosomal acidification, possibly through v-ATPase activity, is required for mTORC1 
activation.  Second, both lysosomal acidification and mTORC1 activation are dependent 
on the amputation plane along the P-D axis.  Third, an amino acid transporter Slc7a5 is 
necessary for mTORC1 activation and the expression of growth factor-related genes.  
Fourth, leucine and glutamine, which functions upstream of v-ATPase/lysosomal 
acidification, have the ability to increase cell proliferation via mTORC1 activation in both 
proximal and distal fin regenerates.  Based on our results, we propose a molecular 
pathway that leads to the position-dependent cell proliferation during zebrafish caudal fin 
regeneration (Fig. S11).  Leucine and glutamine are proximally enriched in unamputated 
fins as shown previously [10].  Leucine/glutamine signaling via Slc7a5 initiates v-
ATPase activity in a position-dependent manner and causes lysosomal acidification.  
The position-dependent v-ATPase activity/lysosomal acidification activates the mTORC1 
signaling, which leads to cell proliferation and upregulation of growth factor-related gene 
expression directly or indirectly. 
In addition to leucine/glutamine, mTORC1 senses and responds to various stresses, 
such as energetic/metabolic stress and oxidative stress, but most of these stresses are 
repressive [29].  In contrast, a previous report using a cell culture system revealed that 
oxidative stress activates mTORC1 through modulating the TSC1/TSC2-Rheb GTPase 
pathway [30].  Oxidative stress is one of main regulation factors for zebrafish cauda fin 
regeneration: reactive oxygen species (ROS), such as H2O2, production was gradually 
increased at the amputation plane by 16 hpa [31], and nerves and H2O2 levels controlled 
each other in a positive feedback loop [32].  Moreover, the spatial and temporal 
localization of ROS is closely similar to that of lysosome acidification.  These previous 
data, combined with our results, suggest that oxidative stress might be one of upstream 
regulators for mTORC1 activation. 
Double staining experiments with p-S6K and LysoTracker showed that approximately 
55 % of p-S6K-positive cells were fluorescent LysoTracker-negative at 3 hpa (Fig. 3H-
K).  A possible explanation for this result is that lysosomal acidification probably 
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occurred before 3 hpa and therefore, LysoTracker fluorescence had already disappeared 
at 3 hpa.  Another possibility is that upstream environmental signals of mTORC1 other 
than amino acids and growth factors, such as oxygen and energy, activate mTORC1 
within 3 hpa.  It would be pertinent to explore these upstream environmental signals that 
function in mTORC1 activation immediately after fin-amputation. 
Recently, three amino acids (leucine, glutamine, and arginine) were implicated in the 
activation of mTORC1 through various amino acid sensing mechanisms [15,25,33].  
Some amino acid sensing mechanisms for mTORC1 activation have been reported: 
binding of cytosolic leucine and Sestrin2, or cytosolic arginine and Cellular Arginine 
Sensor for mTORC1 (CASTOR1), prevents Sestrin2-GAP activity towards Rags2 
(GATOR2), or CASTOR1-GATOR2 interaction via GATOR1 inactivation, leading to 
increased Rag-dependent mTORC1 signaling, respectively [15,25,33]; glutamine and 
leucine activate mTORC1 via glutaminolysis and -ketoglutarate production upstream of 
Rag [34]; mTORC1 is activated by glutamine via adenosine diphosphate ribosylation 
factor-1 dependent on v-ATPase [35].  In this study, we showed that individual leucine 
or glutamine treatments had no effect on mTORC1 activation during fin regeneration, 
whereas treatment of both leucine and glutamine activated mTORC1 signaling.  There 
are two possible explanations for this result; one is that both amino acids are required for 
mTORC1 activation as in the glutaminolysis and -ketoglutarate production pathway, as 
mentioned above; while the other possibility is that, because Lat1 (Slc7a5) and 4F2hc 
(Slc3a2) are bi-directional transporters 36, leucine is transported into the cytosol instead 
of the glutamine efflux.  A recent study revealed that Lat1/4F2hc is recruited by 
lysosomal-associated transmembrane protein 4b (LAPTM4b) to the lysosome [37].  
This recruitment leads to uptake of leucine into the lysosome and is required for mTORC1 
activation depending on v-ATPase activity.  These previous results are consistent with 
our results that show the axis of leucine/glutamine signaling-v-ATPase/lysosomal 
acidification is associated with mTORC1 activation.  Further studies are needed to 
elucidate how leucine and glutamine activate mTORC1 during fin regeneration. 
Previous reports revealed that the H+ pump v-ATPase activity is necessary for 
regeneration of Xenopus larval tail [38] and zebrafish caudal fin [16].  In Xenopus larvae, 
v-ATPase mRNA and protein are expressed in the regeneration bud, and its protein is 
localized in the cell-membrane of the bud cells [38].  The v-ATPase activity changes 
membrane voltage in the bud cells via the H+ efflux and repolarization by its activity is 
necessary for tail outgrowth [38].  Like the Xenopus larval tail, H+ efflux via v-ATPase 
is required for blastema cell proliferation in zebrafish caudal fin regeneration at 24 and 
48 hpa [16].  In addition to the previous study results, we also found that lysosomal 
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acidification, possibly through v-ATPase, is required for activation of mTORC1 signaling 
within 3 hpa.  To date, only one study reported that lysosomal pH functions not only in 
mTORC1 activation, but also in its deactivation via protein degradation in osteoclasts 
[39].  It is possible that lysosomal pH itself may affect the amino acid transportation into 
the lysosome, amino acid sensing in the lysosome, or formation of the Rag/Regulator/v-
ATPase complex formation on the lysosome membrane.  Our results combined with 
previous data showed that v-ATPase has dual functions in both lysosomal pH control and 
plasma membrane voltage for zebrafish caudal fin regeneration at different regeneration 
stages. 
However, the most important finding of this study is that leucine/glutamine and v-
ATPase/lysosomal acidification via mTORC1 activation are required for the position-
dependent fin regeneration.  A recent report showed by metabolomic analyses that many 
specific amino acids are proximally or distally enriched in uninjured zebrafish caudal fin 
along the P-D axis.  Both leucine and glutamine were identified as proximally-enriched 
amino acids [10].  In addition, the expression of atp6v1e1b, a component of the v-
ATPase complex, in the proximal regenerates was higher than that in the distal regenerates 
[16].  In this study, we also showed that the expression of slc7a5, encoding L-type amino 
acid transporter, in the proximal regenerates was higher than that in the distal regenerates 
at 3 hpa, and that treatment with leucine and glutamine lead to the upregulation of PCNA 
expression in the distal regenerates at 36 hpa.  Furthermore, inhibition of 
leucine/glutamine signaling and lysosomal acidification resulted in downregulation of 
growth factor gene expression, such as wnt10a, igf2b, aldh1a2, and fgf20a.  
Cumulatively, these results suggest that the axis of leucine/glutamine signaling-v-
ATPase/lysosomal acidification via mTORC1 activation is a potent candidate effector of 
the position-dependent regeneration along the P-D axis at the early stage of fin 
regeneration (within 3 hpa).  Moreover, differences in cell proliferation along the P-D 
axis are regulated by mTORC1 or possibly by growth factors downstream of this axis. 
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Materials and Methods 
 
Zebrafish husbandry, drug treatments, LysoTracker staining, amino acid 
treatments, and morpholino knockdown 
All zebrafish experiments were conducted in strict accordance with relevant nation and 
international guidelines: ‘Act on Welfare and Management of Animals’ (Ministry of 
Environment of Japan), and were approved by the Hiroshima University Animal Research 
Committee (Permit Number: F17-2).  For caudal fin amputation, adult zebrafish 
(AB/Tüebingen strain) were anesthetize using Tricaine (Sigma-Aldrich) and the caudal 
fins were amputated with razor blades along the dorsoventral axis.  The proximal or 
distal amputations were performed as described previously [16]; for distal amputation, 
one or two ray segments were cut before the first ray bifurcation, and for proximal 
amputation, two segments distal to the most posterior scale covering the fin base were 
cut.  In case amputation position is not specified, caudal fins were amputated at the 
proximal position. 
Rapamycin (2.4 M, LC Laboratories), NVP-ADW742 (5 M, AdooQ Biosciences), 
IWP-2 (10 M, Promega), CQ (4.5 mM, Sigma-Aldrich), NH4Cl (5 mM, Sigma-Aldrich), 
and JPH203 (40 M, Chemescene) were used as specific inhibitors.  All inhibitors, 
except CQ and NH4Cl, were dissolved in DMSO, with a 0.1% final DMSO concentration 
in fish water.  The control fish were maintained in fish water (for CQ and NH4Cl) or 
with 0.1% DMSO (for rapamycin, NVP-ADW742, IWP-2, and JPH203) at 28.5 ˚C and 
this water containing respective drug was replaced daily.  These treatments started 12 h 
before fin amputation.  Two fish were placed in 50 ml of fish water containing respective 
drug and during the drug treatment, the fish were fed once a day.  ConcA (200 nM, Santa 
Cruz Biotechnology) or BafA1 (200 nM, Cell Signaling) were dissolved in 100 % DMSO 
and diluted in Danieau medium 16.  This diluted solution was injected into amputated 
fins at 1 hpa. 
For LysoTracker staining, fin-amputated adult fish were incubated in LysoTracker Red 
DND-99 (ThermoFisher Scientific) solution diluted in fish water (1:1000) at 28.5 ˚C for 
15 min before live imaging.  To observe longitudinal ray sections, 2 nl of the diluted 
LysoTracker solution (1 M) was injected directly into the 2nd, 3rd, and 4th fin rays from 
the dorsal and ventral amputated fins below the amputation plane.  For leucine and 
glutamine treatment, the fish were incubated in the fish water containing 5, 15, and 25 
mM L-leucine (Sigma-Aldrich) and/or L-glutamine (Sigma-Aldrich).  The fish water 
containing of the two amino acids was replaced every 12 h. 
For MO knockdown experiments, we used vivo-MO targeted against slc7a5 and 
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standard control vivo-MO (st-MO) (GeneTools, LLC) as following: slc7a5 vivo-MO 
(slc7a5-MO) 5’-AGGTAACAGTTTACTTACGTATACA-3’ [26], st-MO 5’-
CCTCTTACCTCAGTTACAATTTTATA-3’.  slc7a5-MO (1 mM) or st-MO (1 mM) 
was injected into each inter-ray 3 h before fin amputation, and then every 12 h before 
observation or harvest, as described previously [40]. 
 
Immunohistochemical staining and detection of cell death 
The amputated fins were fixed overnight in 4% paraformaldehyde in 0.1 M phosphate-
buffered saline at 4 ˚C, embedded in Tissue-Tek O.C.T compound (Sakura Finetek), and 
cryosectioned to 14 m thickness by using a Leica CM3050S [17].  The following 
primary antibodies were used: anti-PCNA mouse monoclonal antibody at 1:1000 (Sigma, 
#P8825) and phospho-S6 ribosomal protein (Ser240/244) rabbit polyclonal antibody at 
1:300 (Cell Signaling, #2215).  The following secondary antibodies were used: Alexa 
Fluor® 488 goat anti-rabbit IgG antibody at 1:500 (Invitrogen, Life Technologies Corp.) 
and Alexa Fluor® 594 goat anti-mouse IgG antibody at 1:500 (Invitrogen, Life 
Technologies Corp.).  4',6-diamidino-2-phenylindole (DAPI) was used for nuclei 
staining at a concentration of 1:1000.  To detection apoptotic cells, we performed 
TUNEL staining using an In situ cell death detection kit (Roche, #11684795910) 
according to the manufacturer’s instructions.  The images were captured using an 
Olympus FV1000-D confocal microscope with the same exposure times using the 
FluoView software.  Eight optical sections per one cryosection along the z-axis were 
taken in 0.67 m intervals, and the captured images were analyzed using ImageJ (NIH). 
 
qPCR analyses 
Extraction of total RNA from regenerating fins was performed as described previously 
41.  Five independent qPCR experiments of ten genes (wnt10a, igf2b, aldh1a2, fgf20a, 
slc7a5, slc7a8a, slc7a8b, slc43a1a, slc43a1b, and ribosomal protein L13a (rpl13a)) for 
gene expression and MO efficacy was performed in duplicates using the Thermal Cycler 
Dice Real-Time System II and SYBR Premix Ex Taq II (TAKARA) as described 
previously [42].  Zebrafish rpl13a was used as a reference gene.  The qPCR primers 
are listed in Table S1. 
 
LysoTracker image analyses 
Fluorescent LysoTracker images were acquired using a Leica MZ FLIII microscope and 
Penguin 600CL cooled CCD camera (Pixera).  As described previously [43], average 
LysoTracker fluorescence intensity was measured using the ImageJ software (NIH) with 
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the following formula: [integrated intensity in the whole amputation plane area (W 500 
μm × L full-length of the amputation plane) – mean fluorescence intensity of background]. 
 
Western blotting 
Western blotting was performed as described previously [44].  Fins were lysed in 2 × 
SDS-sample buffer (125mM Tris-HCl (pH 6.8), 4% SDS, 20% Glycerol, 0.01% 
bromophenol blue, 2% 2-mercaptoethanol) containing a protease inhibitor cocktail 
(Roche, #11836153001) and a phosphatase inhibitor cocktail (Nacalai, #07574-61).  
Total proteins (5 g) were separated by SDS-PAGE and transferred to a polyvinylidene 
fluoride (PVDF) membrane.  The PVDF membranes were incubated overnight with 
primary antibodies: anti-γTubulin (Sigma-Aldrich, #T6557) at 1:20000, ribosomal 
protein S6 Antibody (C-8) (Santa Cruz Biotechnology, #sc-74459) at 1:1000, and anti-
phospho-S6 ribosomal protein (Ser240/244) (Cell signaling, #2215) at 1:1000.  For 
detection, horseradish peroxidase-coupled secondary antibodies: goat anti-mouse IgG-
HRP at 1:10000 (Santa Cruz Biotechnology, #sc-2055) and mouse anti-rabbit IgG-HRP 
at 1:10000 (Santa Cruz Biotechnology, #sc-2357), and the ECL Prime Western Blotting 
Detection Reagent (GE Healthcare, #RPN2232) were used, according to the 
manufacturer’s instructions.  A densitometric analysis of the western blotting was 
performed using ImageJ, with Tubulin for normalization. 
 
Statistical analyses 
All experiments were performed independently more than three times and the results 
were reported as means ± Standard Error of Mean (SEM).  More than 100 cells for distal 
amputation and 500 cells for proximal amputation were used for quantification of 
fluorescence intensity (for p-S6K and LysoTracker) or quantification of RLT, RPT, and 
percentage of TUNEL+ cells.  Statistical significance was determined by using the 
Student’s t-test.  p values of ≤0.05 were considered to be statistically significant. 
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FIGURES 
 
 
Figure 1. Activation of S6K was not inhibited by pharmacological inhibitors of IGF 
or Wnt signaling at 3 hpa. 
(A) Scheme of inhibitor treatments for rapamycin (a mTORC1 inhibitor), NVP-
ADW742 (an IGF-1R inhibitor), and IWP-2 (a Wnt/-catenin inhibitor) from -12 to 12 
hpa.  (B) Bright-field images of longitudinal ray sections of wild-type (WT) stumps (0 
and 1-12 hpa) and fin regenerates (36 hpa).  Black and red dotted lines indicate the 
amputation planes (amp) and the border between epidermis and blastema, respectively.  
(C-F’, H-K’, and M-P’) Longitudinal ray sections of DMSO- or inhibitors-treated WT fin 
stumps that were immunohistochemically stained with an antibody against p-S6K (green) 
at 3, 6, and 12 hpa (n = 5).  4,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
fluorescent signal (grayscale; pseudo color) indicates the presence of nuclei.  
Representative images used for quantification are shown in G, L, and Q along with a 
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highly magnified view.  White dashed lines indicate the amputation planes.  Scale bars: 
50 m (C-F, H-K, and M-P) and 25 m (C’-F’, H’-K’, and M’-P’).  (G, L, and Q) 
Quantification of the p-S6K fluorescence intensities per area that consist of the whole 
regenerates and 500 m below the amputation plane (including the intra-ray, epidermal, 
and wound epidermal cells) in rapamycin-, NVP-ADW742-, or IWP-2-treated fin stumps 
at 3 (G), 6 (L), and 12 (Q) hpa (n = 5).  n.s.: not significant.  ***p < 0.001 by Student’s 
t test.  Error bars represent the standard error. 
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Figure 2. v-ATPase activity is required for the S6K activation. 
(A) Experimental scheme.  DMSO, ConcA, or BafA1 solution was injected into the 
amputated fins at 1 hpa.  The red two-headed-arrow indicates LysoTracker treatment, 
which was applied 15 min before observation.  (B-E) Longitudinal ray sections and 
quantification of p-S6K fluorescence intensities per area that consist of the whole 
regenerates and 500 m below the amputation plane in DMSO-, ConcA-, or BafA1-
treated fin stumps at 3 hpa; p-S6K and nuclei were visualized by immunohistochemical 
staining and DAPI staining, respectively (n = 5).  Representative images (B-D’) used for 
quantification are shown in E.  White dashed lines indicate the amputation planes.  
Scale bars: 50 m (B-D) and 25 m (B’-D’).  ***p < 0.001 by Student’s t test.  Error 
bars represent the standard error.  (F) Western blotting analysis of Tubulin, S6K, and p-
S6K in the DMSO-, ConcA-, or BafA1-treated fin stumps at 3 hpa (n = 6).  Tubulin 
serves as a loading control.  Numbers below each lane show the level of p-S6K in 
ConcA-, or BafA1-treated fin stumps relative to that in DMSO-treated fin stumps at 3 hpa 
normalized to loading control.  (G-I’) Images of bright-field and fluorescence (red) 
microscopy, and quantification of the LysoTracker fluorescence intensity (see Materials 
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and Methods) of DMSO-, ConcA-, or BafA1-treated fin stumps (n = 8).  Black boxed 
areas in G-I are enlarged in G’-I’, respectively.  The LysoTracker fluorescence 
intensities in red boxed areas were measured (G-I’).  Representative images (G’-I’) used 
for quantification are shown in J.  White dashed lines indicate the amputation planes.  
Scale bars: 1 mm (G-H) and 500 m (G’-H’).  ***p < 0.001 by Student’s t test.  Error 
bars represent the standard error. 
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Figure 3. Requirement of lysosomal acidification in the S6K activation. 
(A) Experimental scheme.  NH4Cl or chloroquine (CQ) was treated from -12 to 3 or 
24 hpa (B-G).  LysoTracker solution was injected into the amputated fins 15 min before 
fixation (H-K).  (B-E) Longitudinal ray sections and quantification of p-S6K 
fluorescence intensities per area that consist of the whole regenerates and 500 m below 
the amputation plane in control, NH4Cl-, or CQ-treated fin stumps at 3 hpa; p-S6K and 
nuclei were visualized by immunohistochemical staining and DAPI staining, respectively 
(n = 5).  Representative images (B-D’) used for quantification are shown in E.  White 
dashed lines indicate the amputation planes.  Scale bars: 50 m (B-D) and 25 m (B’-
D’).  ***p < 0.001 by Student’s t test.  Error bars represent the standard error.  (F) 
Western blotting analysis of Tubulin, S6K, and p-S6K in the DMSO-, NH4Cl-, or CQ-
treated fin stumps at 3 hpa.  Tubulin serves as a loading control.  Numbers below each 
lane show the level of p-S6K in NH4Cl-, or CQ-treated fin stumps relative to that in 
DMSO-treated fin stumps at 3 hpa normalized to loading control.  (G) The relative 
expression of growth factor-related genes in NH4Cl- or CQ-treated fin stumps by qPCR 
at 24 hpa.  ***p < 0.001, ** p < 0.05 by Student’s t test.  Error bars represent the 
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standard error.  (H-K) Longitudinal ray sections and quantification of p-S6K+ and 
LysoTracker fluorescence+ cells in area that consist of the whole regenerates and 500 m 
below the amputation plane at 3 hpa; p-S6K (green), nuclei (grayscale), and lysosomal 
acidification (red) were visualized by immunohistochemical staining, DAPI, and 
LysoTracker (Lyso.), respectively (n = 8).  White boxed areas in H are enlarged in I-J’, 
respectively.  Representative images (H-J’) used for quantification are shown in K.  
Arrowheads in I’ and J’ indicate LysoTracker fluorescence and p-S6K double positive 
cells.  Scale bars: 50 m (H) and 25m (I-J’).  A pie chart shows that 55.4 % of p-
S6K+ cells are the LysoTracker fluorescence positive cells (K). 
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Figure 4. Position-dependent lysosomal acidification during fin regeneration. 
(A) Experimental scheme.  Red two-headed-arrows indicate LysoTracker treatment, 
which was applied 15 min before observation.  For cryosections, LysoTracker solution 
was injected into the amputated fins 15 min before fixation.  (B-E’’) Bright-field and 
fluorescent images of LysoTracker-treated fins at 1, 3, 6, and 12 hpa (n = 5).  Black 
boxed areas in B-E are enlarged in B’-E’ and B’’-E’’, respectively.  The LysoTracker 
fluorescence intensities in red boxed areas were measured (B-E’’).  Representative 
images (B’-E’’) used for quantification are shown in F.  White dashed lines indicate the 
amputation planes.  Scale bars: 3 mm (B-E) and 500 m (B’-E’ and B’’-E’’).  (F) 
Quantification of Lysotracker fluorescence intensities at the proximal and distal positions 
at 1, 3, 6, and 12 hpa (n = 5).  n.s.: not significant.  ***p < 0.001, ** p < 0.05 by 
39 
 
Student’s t test.  Error bars represent the standard error.  (G-I) Longitudinal ray 
sections and quantification of ratios of LysoTracker fluorescence-positive cell 
number/total cell number (RLTs) within 500 m of the amputation plane at 3 hpa (n = 5).  
Representative images (G and H) used for quantification are shown in I.  Arrowheads 
indicate LysoTracker fluorescence-positive cells (red). Scale bars: 50 µm (G and H)  
n.s.: not significant.  ***p < 0.001 by Student’s t test.  Error bars represent the standard 
error. 
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Figure 5. The position-dependent activation of S6K during fin regeneration. 
(A-E) Longitudinal ray sections (3 and 12 hpa) and quantification of p-S6K 
fluorescence intensities per area that consist of the whole regenerates and 500 m below 
the amputation plane (3, 6, 12, and 18 hpa) of proximal and distal positions in WT fins; 
p-S6K and nuclei were visualized by immunohistochemical staining and DAPI staining, 
respectively (n = 8).  Representative images (A-D’) used for quantification are shown in 
E.  White dashed lines indicate the amputation planes.  Scale bars: 50 m (A-D) and 
25m (A’-D’).  ***p < 0.001 by Student’s t test.  Error bars represent the standard error.  
(F) Western blotting analysis of Tubulin, S6K, and p-S6K in WT fin stumps at 3 and 12 
hpa.  Tubulin serves as a loading control.  Numbers below each lane show the level of 
p-S6K in proximal fin stumps relative to that in distal fin stumps at 3 or 12 hpa normalized 
to loading control, respectively.  (G-J) Longitudinal ray sections of proximal and distal 
fins in WT fins at 36 and 48 hpa; PCNA and nuclei were visualized by 
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immunohistochemical staining and DAPI staining, respectively (n = 5).  Representative 
images (G-J) used for quantification are shown in K.  White dashed lines indicate the 
amputation planes.  Scale bars: 50 m (G-J).  (K) Ratios of PCNA-positive cell 
number/total cell number (RPTs) in whole regenerates at 36 and 48 hpa (n = 5).  ***p < 
0.001 by Student’s t test.  Error bars represent the standard error. 
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Figure 6. Slc7a5 is required for S6K activation and lysosomal acidification. 
(A) The relative expression of slc7a5 in proximal and distal fin regenerates at 0, 1, 3, 
6, and 12 hpa by qPCR analyses.  (B) Scheme of vivo-MO mediated knockdown 
experiments from -3 to 48 hpa.  A red two-headed-arrow indicates LysoTracker 
treatment, which was applied 15 min before observation.  Syringes indicate vivo-MO 
injection.  (C-F) Outgrowth of fin regenerates and quantification of their length after 
being injected with standard vivo-MO (st-MO) or slc7a5 vivo-MO (slc7a5-MO) at 48 
hpa (n = 5).  The boxed areas in C are enlarged in D and E, respectively.  
Representative images (C-E) used for quantification are shown in F.  Black dashed lines 
indicate the amputation planes.  Scale bars: 1 mm (C) and 250 m (D and E).  ***p < 
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0.001 by Student’s t test.  Error bars represent the standard error.  (G-I) Longitudinal 
ray sections and quantification of p-S6K fluorescence intensities per area that consist of 
the whole regenerates and 500 m below the amputation plane in st-MO or slc7a5-MO 
injected fin stumps at 3 hpa; p-S6K and nuclei were visualized by immunohistochemical 
staining and DAPI staining, respectively (n = 8).  Representative images (G-H’) used 
for quantification are shown in I.  Scale bars: 50 m (G and H) and 25 m (G’-H’).  
***p < 0.001 by Student’s t test.  Error bars represent the standard error.  (J) Western 
blotting analysis of Tubulin, S6K, and p-S6K in st-MO or slc7a5-MO injected fin stumps 
at 3 hpa (n = 5).  Tubulin serves as a loading control.  Numbers below each lane show 
the level of p-S6K in st-MO injected fin stumps relative to that in slc7a5-MO injected fin 
stumps at 3 hpa normalized to loading control.  (K) The relative expression of growth 
factor-related genes in st-MO- or slc7a5-MO-injected fins by qPCR at 24 hpa.  ***p < 
0.001.  Error bars represent the standard error.  (L-N) Images of bright-field and 
fluorescence microscopy, and quantification of LysoTracker fluorescence intensities in 
st-MO- or slc7a5-MO-injected fin stumps at 3 hpa (n = 5).  Black boxed areas in L and 
M are enlarged in L’ and M’, respectively.  The LysoTracker fluorescence intensities in 
red boxed areas were measured (L-M’).  Representative images (L’-M’) used for 
quantification are shown in N.  Scale bars: 1 mm (L and M) and 500 m (L’ and M’).  
***p < 0.001.  Error bars represent the standard error. 
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Figure 7. Leucine and glutamine treatment activates mTORC1 signaling via v-
ATPase activity and lysosomal acidification. 
(A) Experimental scheme.  (B-F) Longitudinal ray sections (3 hpa) and 
quantification of p-S6K fluorescence intensities per area that consist of the whole 
regenerates and 500 m below the amputation plane (3, 6, and 12 hpa) of proximal and 
distal positions in control or LG-treated fin regenerates; p-S6K and nuclei were visualized 
by immunohistochemical staining and DAPI staining, respectively (n = 6).  
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Representative images (B-E) used for quantification are shown in F.  White dashed lines 
indicate the amputation planes.  Scale bars: 50 m.  ***p < 0.001 by Student’s t test.  
Error bars represent the standard error.  (G) Western blotting analysis of Tubulin, S6K, 
and p-S6K in proximally and distally amputated LG-treated fin stumps at 3 hpa.  
Tubulin serves as a loading control.  Numbers below each lane show the level of p-S6K 
in proximally or distally amputated LG-treated fin stumps relative to that in proximally 
or distally amputated control fin stumps at 3 hpa normalized to loading control, 
respectively.  (H-L) Longitudinal ray sections and RPT quantification in proximally and 
distally amputated control or LG-treated fin regenerates at 36 hpa; PCNA and nuclei were 
visualized by immunohistochemical staining and DAPI staining, respectively (n = 5).  
Representative images (H-K) used for quantification are shown in L.  White dashed lines 
indicate the amputation planes.  Scale bars: 50 m.  ***p < 0.001 by Student’s t test.  
Error bars represent the standard error.  (M) The relative expression of growth factor-
related genes in control and LG-treated fin regenerates by qPCR at 24 hpa.  n.s.: not 
significant.  ***p < 0.001 by Student’s t test.  Error bars represent the standard error.  
(N-S) Longitudinal ray sections and quantification of p-S6K fluorescence intensities per 
area that consist of the whole regenerates and 500 m below the amputation plane in 
control, LG-treated, LG-treated and DMSO-injected (LG + DMSO), LG-treated and 
ConcA-injected (LG + ConcA), or LG- and NH4Cl-treated (LG + NH4Cl) fin stumps at 
3 hpa; p-S6K and nuclei were visualized by immunohistochemical staining and DAPI 
staining, respectively (n = 5).  Representative images (N-R) used for quantification are 
shown in S.  White dashed lines indicate the amputation planes.  Scale bars: 50 m.  
***p < 0.001 by Student’s t test.  Error bars represent the standard error.  (T) Western 
blotting analysis of Tubulin, S6K, and p-S6K in control, LG-treated, LG + DMSO, LG 
+ ConcA, or LG + NH4Cl fin stumps at 3 hpa (n=6).  Tubulin serves as a loading 
control.  Numbers below each lane show the level of p-S6K in LG-treated, LG + DMSO, 
LG + ConcA, or LG + NH4Cl fin stumps relative to that in control fin stumps at 3 hpa 
normalized to loading control. 
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Supplementary figures 
 
 
Figure S1. Western blot analysis of rapamycin-, NVP-ADW742-, or IWP-2-treated 
fin stumps. 
Western blot analysis of Tubulin, S6K, and p-S6K in rapamycin-, NVP-ADW742-, 
or IWP-2-treated fin stumps at 3 and 12 hpa (n = 5).  Tubulin serves as a loading control.  
Numbers below each lane show the level of p-S6K in rapamycin-, NVP-ADW742-, or 
IWP-2-treated fin stumps relative to that in DMSO-treated fin stumps at 3 or 12 hpa 
normalized to loading control, respectively. 
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Figure S2. Lysosomal acidification during fin regeneration. 
(A) Experimental scheme.  Red two-headed-arrows indicate LysoTracker treatment, 
which was applied 15 min before observation.  (B-F’) Images of bright-field and 
fluorescence microscopy, and quantification of LysoTracker fluorescence intensities at 0, 
3, 6, 12, and 24 hpa (n = 5).  Black boxed areas in B-F are enlarged in B’-F’, respectively.  
The LysoTracker fluorescence intensities in red boxed areas were measured (B-F’).  
Representative images (B’-F’) used for quantification are shown in G.  White dashed 
lines indicate the amputation planes.  Scale bars: 1 mm (B-F) and 500 m (B’-F’).  n.s.: 
not significant.  ***p < 0.001 by Student’s t test.  Error bars represent the standard 
error. 
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Figure S3. Lysosomal acidification in NH4Cl- and CQ-treated fins. 
(A) Experimental scheme.  A red two-headed-arrows indicates LysoTracker 
treatment, which was applied 15 min before observation.  (B-E) Images of bright-field 
and fluorescence microscopy, and quantification of LysoTracker fluorescence intensities 
in control, NH4Cl-, or CQ-treated fins at 3 hpa (n = 8).  Black boxed areas in B-D are 
enlarged in B’-D’, respectively.  The LysoTracker fluorescence intensities in red boxed 
areas were measured (B-D’).  Representative images (B’-D’) used for quantification are 
shown in E.  White dashed lines indicate the amputation planes.  Scale bars: 1 mm (B-
D) and 500 m (B’-D’).  ***p < 0.001 by Student’s t test.  Error bars represent the 
standard error. 
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Figure S4. Detection of apoptotic cells by NH4Cl- or CQ-treatment. 
(A) Experimental scheme.  NH4Cl or chloroquine (CQ) was treated from -12 to 3 or 
24 hpa.  (B-G) Longitudinal ray sections and quantification of TUNEL positive 
cells/total cell number per area that consists of the whole regenerates and 500 m below 
the amputation plane in control, NH4Cl-, or CQ-treated fin stumps at 3 and 24 hpa; 
apoptotic cells and nuclei were visualized by immunohistochemical staining and DAPI 
staining, respectively (n = 5).  Representative images (B-G) used for quantification are 
shown in H.  White dashed lines indicate the amputation planes.  Scale bars: 50 m (B-
G).  n.s.: not significant.  Error bars represent the standard error. 
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Figure S5. Expression of LATs genes during fin regeneration. 
The relative expression of the four LATs genes (slc7a8a, slc7a8b, slc43a1a, and 
slc43a1b) at 0, 3, 6, and 12 hpa by qPCR.  Error bars represent the standard error. 
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Figure S6. slc7a5 pre-mRNA splicing was blocked by vivo-MO. 
(A) Scheme of the slc7a5 pre-mRNA regions analyzed for splicing (boxed, exons; 
lines, introns; arrows, primers).  (B) Spliced PCR products of slc7a5, obtained by qPCR, 
were significantly reduced in slc7a5-MO-injected fins when compared to in st-MO-
injected fins by qPCR.  ***p < 0.001 by Student’s t test.  Error bars represent the 
standard error. 
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Figure S7. S6K activation and lysosomal acidification are inhibited by JPH203. 
(A) Scheme of JPH203 (Slc7a5-specific inhibitor) treatment from -12 to 3 or 48 hpa.  
A red two-headed-arrow indicates LysoTracker treatment, which was applied 15 min 
before observation.  (B-D) Outgrowth of fin regenerates and quantification of their 
length in control or JPH203-treated fin regenerates at 48 hpa (n = 5).  Representative 
images (B and C) used for quantification are shown in D.  Black dashed lines indicate 
the amputation planes.  Scale bars: 250 m.  ***p < 0.001 by Student’s t test.  Error 
bars represent the standard error.  (E-G) Longitudinal ray sections and quantification of 
p-S6K fluorescence intensities per area that consists of the whole regenerates and 500 m 
below the amputation plane in DMSO- or JPH203-treated fin regenerates at 3 hpa; p-S6K 
and nuclei were visualized by immunohistochemical staining and DAPI staining, 
respectively (n = 5).  Representative images (E-F’) used for quantification are shown in 
G.  White dashed lines indicate the amputation planes.  Scale bars: 50 m (E and F) 
and 25 m (E’ and F’).  ***p < 0.001 by Student’s t test.  Error bars represent the 
standard error.  (H) Western blot analysis of Tubulin, S6K, and p-S6K in the DMSO- 
or JPH203-treated fin stumps (n = 6).  Tubulin serves as a loading control.  Numbers 
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below each lane show the level of p-S6K in JPH203-treated fin stumps relative to that in 
DMSO-treated fin stumps at 3 hpa normalized to loading control.  (I-K) Images of 
bright-field and fluorescence microscopy, and quantification of LysoTracker fluorescence 
intensities in DMSO- or JPH203-treated fins at 3 hpa (n = 8).  Black boxed areas in I 
and J are enlarged in I’ and J’, respectively.  The LysoTracker fluorescence intensities in 
red boxed areas were measured (I-J’).  Representative images (I’-J’) used for 
quantification are shown in K.  White dashed lines indicate the amputation planes.  
Scale bars: 1 mm (I and J) and 500 m (I’ and J’).  ***p < 0.001 by Student’s t test.  
Error bars represent the standard error. 
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Figure S8. Leucine or glutamine treatment has no effect on S6K activation. 
(A) Experimental scheme of leucine or glutamine treatment from -12 to 3 hpa.  (B-
E) Longitudinal ray sections and quantification of p-S6K fluorescence intensities per area 
that consists of the whole regenerates and 500 m below the amputation plane in control, 
leucine-, or glutamine-treated fin regenerates at 3 hpa; p-S6K and nuclei were visualized 
by immunohistochemical staining and DAPI staining, respectively (n = 5).  
Representative images (B-D’) used for quantification are shown in E.  White dashed 
lines indicate the amputation planes.  Scale bars: 50 m.  n.s.: not significant.  Error 
bars represent the standard error. 
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Figure S9. LG treatment up-regulates lysosomal acidification in a concentration-
dependent manner. 
(A) Experimental scheme of leucine and/or glutamine treatment from -12 to 3 hpa.  
A red two-headed-arrow indicates LysoTracker treatment, which was applied 15 min 
before observation.  (B-P) Images of bright-field and fluorescence microscopy, and 
quantification of LysoTracker fluorescence intensities in fin stumps at 3 hpa (n = 6).  
Black boxed areas in B-E, G-J, and L-O are enlarged in B’-E’, G’-J’, and L’-O’, 
respectively.  The LysoTracker fluorescence intensities in red boxed area were measured 
(B-E’, G-J’, and L-O’).  Representative images (B-E’, G-J’, and L-O’) used for 
quantification are shown in F, K, and P.  White dashed lines indicate the amputation 
planes.  Scale bars: 1 mm (B-E, G-J, and L-O) and 500 m (B’-E’, G’-J’, and L’-O’).  
***p < 0.001 by Student’s t test.  Error bars represent the standard error. 
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Figure S10. Upregulation of lysosome acidification by LG treatment is blocked by 
Slc7a5 knockdown. 
(A) Experimental scheme of LG treatment from -12 to 3 hpa.  A red two-headed-
arrow indicates LysoTracker treatment, which was applied 15 min before observation.  
A syringe indicates vivo-MO injection at -3 hpa.  (B-D’) Images of bright-field and 
fluorescence microscopy, and quantification of LysoTracker fluorescence intensities in 
st-MO-, LG-treated and st-MO-injected (LG + st-MO), or LG-treated and slc7a5-MO-
injected (LG + slc7a5-MO) fin stumps at 3 hpa (n = 6).  Black boxed areas in B-D are 
enlarged in B’-D’, respectively.  The LysoTracker fluorescence intensities in red boxed 
areas were measured (B-D’).  Representative images (B’-D’) used for quantification are 
shown in E.  Scale bars: 1 mm (B-D) and 500 m (B’-D’).  ***p < 0.001.  Error bars 
represent the standard error. 
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Figure S11. A proposed model of position-dependent fin regeneration in zebrafish. 
For discussion, see text.  Leucine and glutamine are proximally enriched in 
unamputated fins.  The position-dependency of slc7a5 expression, lysosomal 
acidification, and mTORC1 activity is found in this study (marked by red boxes). 
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Table S1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Primer sequences 5' to 3'  
Gene name Forward primer Reverse primer Ref. 
qRT-PCR   
  wnt10a ATTCACTCCAGGATGAGACTTCATA GTTTCTGTTGTGGGCTTTGATTAG 1 
  igf2b GCAGGTCATTCCAGTGATGC TCTGAGCAGCCTTTCTTTGC 2 
  aldh1a2 GCTTACCTTGCTACCCTGGAGTC CAATGGGCTCATGTCTGGTGAG This study 
  fgf20a GGACCACAGCAGATTTGGTATATTGG CAGCTTTTCAGATCCGTACAGTTCGC This study 
  slc7a5 GGAGATCGGCAAAGGTGATAC GCTCAATCATCTCCTCTGTGAC This study 
  slc7a8a GCAGGGTTTCTGCGATTATGG CAAGTCAGCAGCAACAAGCAG This study 
  slc7a8b CAGCAAGAAGAGCAGGAATGG GTTTGGAAGTCTCTCTGTGCC This study 
  slc43a1a CGTAACGTCACGGTTAGCACTT CTTCACCAGTAGCATTCACTGTC This study 
  slc43a1b GGCAGCATCAGGAGAAGAAGTG CGAACACAGCAGGTTCTCCAAC This study 
  rpl13a TCTGGAGGACTGTAAGAGGTATGC AGACGCACAATCTTGAGAGCAG 3 
checking morpholino efficacy   
  slc7a5 TGAAACTGTGGATCGAGCTG AGGCATCTTGAACCCTTGTG 4 
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General discussion 
 
Positional memory is of one the unsolved issues in the regeneration field. How is 
regeneration regulated such that the organ achieves its original formation? It is an 
important working as well as initiation of regeneration especially in vivo regeneration 
therapy. By resolving this, I believe that this can possibly be applied directly in the therapy 
of function defective organs in the future. 
In this research, we applied approaches to elucidate its mechanism using a simplified 
experimental system on zebrafish fins. Furthermore, we clarified new factors through 
screening experiments using various inhibitors and drugs, revealing a part of the 
mechanism in positional memory. In this study, it was revealed that amino acids, which 
is important in our daily life activity, have a critical function in the process of tail fin 
regeneration. Previously, it was reported that the mTORC1 pathway influences various 
factors involved in regeneration from the early stage during zebrafish tail regeneration 
process. However, the activation of the mTORC1 pathway could be confirmed 
immediately after amputation when the induction of growth factor had not started, so 
other functions of mTORC1 pathway could be expected. What is upstream of the 
mTORC1 pathway in the early stage of fin regeneration? According to the results of this 
study, it was revealed that incorporation of amino acids induced the activation of the 
mTORC1 pathway immediately just after fin amputation. 
Further research revealed that the overtaking of amino acids, particularly leucine which 
is one of the branched amino acids, had been greatly induced in the early stage of 
regeneration with the mediation of the transporter. This branched chain amino acid had 
been known as an important factor in our life [1]. Compared with other amino acids, 
leucine is rapidly incorporated into the body and is known to greatly affect muscle repair 
because the it directly regulates the expression of eukaryotic translation initiation factor 
4E binding protein 1 (4E-BP1) through the mTOR pathway. In recent years, many athletes 
are beginning to incorporate it in muscle enhancing supplement foods [2]. This means 
that taking in leucine, along with other amino acids, is an easier way to improve the 
condition in our body than other therapies. These amino acids have already been reported 
to affect differentiation not only in the muscle cell [3], but also in the pancreatic cell [4], 
neuronal cell [5], and so on [6][7]. However, the mechanism of the amino acid effect has 
been unknown especially in developmental stage and cell differentiation [8][9]. 
In addition, fin regeneration with leucine and glutamine amino acid treatment was 
attempted, but no fin elongation was observed. It was because cell death occurred during 
the fin regeneration with long time amino acid treatment. In general, the amino acid, 
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especially leucine, enters the metabolic pathway with the branched transferase and 
changes various important molecules [10]. One of these processes is the N-acetyl-1-
leucine induced cell death via the p53 pathway, which occurs not only in cancer cells but 
also in some somite cells [11]. In fact, it had been confirmed that the gene expression of 
the branching type amino acid modification enzyme, BCAT, rapidly upregulated the 
expression immediately after fin amputation during regeneration. These results implied 
that the metabolic pathways, N-acetyl-1-leucine related pathway, were activated, and the 
cell death signaling pathway had been activated in same time. Additionally, it had been 
reported that the mTORC1 pathway was activated even in cell death induced cells and 
these reports suggest that the next step is to induce fin regeneration with inhibition of the 
cell death. If the cell death pathway will be inhibited in fin regeneration with leucine and 
glutamine treatment, what will happen during fin regeneration? Can we observe fin 
growth which implies regeneration activation? There is a way to inhibit the cell death 
pathway in zebrafish model system by using the inhibitor of some caspases or the mutant 
in p53. I believe it is possible to activate the regeneration, but the experiment has not been 
done yet.  
Recently, regenerative therapy are hot topics especially by using and in vitro system. 
There are different systems in in vitro therapy, ES cells [12], iPS cells [13], and other cell 
culture system [14][15][16]. If these systems can be applied to our therapy, many people 
who have diseases and defects in the organ or tissue will benefit from these. However, 
these systems still have risks as much as benefits. The most important problem is the high 
risk of carcinoma cells to develop and they have to be clear for our clinical trial. Many 
researchers are trying to find a safer way to apply this therapy. Now, we know in vivo 
regenerative therapy can possibly make therapy application safer. If we can directly 
induce organ or tissue regeneration in our body, will these therapies be rejected by the 
body or will carcinoma develop? Of course, nobody can answer these questions, but we 
know the risk is lower in in vivo than in vitro therapy because we do not need to transplant 
the cells from outside and use the cells derived from others. Additionally, applying the 
treatment inside the body might be less expensive and efficient. I believe that in vivo 
therapy will take the place of the iPS cell or regeneration therapy in the near future. If we 
can directly induce the whole organ or tissue in the body and use an easy treatment, like 
a 2 type amino acid treatment, many people can be treated more effectively. 
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